Pharmaceutical

NorthStar and Convergent expand deal for prostate cancer drug

NorthStar Medical Radioisotopes and Convergent Therapeutics have announced an expanded strategic collaboration for CONV01-α.

Aug 15, 2024 - 04:00
NorthStar and Convergent expand deal for prostate cancer drug
NorthStar Medical Radioisotopes and Convergent Therapeutics have announced an expanded strategic collaboration for CONV01-α.
Read the original article

Tags:

Previous Article

Diabesity: Overlapping pathophysiology informs multi-indication treatment

Next Article

UAE approves BioArctic and Eisai’s Leqembi for Alzheimer’s disease

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Microparticle analysis: methods and uses in the pharmaceutical industry

Microparticle analysis: methods and uses in the pharmac...

May 10, 2023

STAT+: Jay Bradner, former Novartis research leader, to head up Amgen’s scientific efforts

STAT+: Jay Bradner, former Novartis research leader, to...

Dec 15, 2023

STAT+: Colombia proceeds with plans to issue a compulsory license for an HIV medicine sold by GSK’s ViiV

STAT+: Colombia proceeds with plans to issue a compulso...

Feb 7, 2024